Yıl: 2019 Cilt: 26 Sayı: 10 Sayfa Aralığı: 2259 - 2265 Metin Dili: İngilizce DOI: 10.5455/annalsmedres.2019.08.471 İndeks Tarihi: 21-09-2020

Clinical and surgical approach to parathyroid adenomas: A single-center experience

Öz:
Aim: Primary hyperparathyroidism is a clinical condition caused by excessive parathyroid secretion of the parathyroid glands andrelated hypercalsemia. Hyperparathyroidism is a common cause of hypercalcemia. In this study, we aimed to present the results ofpatients operated on due to parathyroidadenoma in our clinic.Material and Methods: IPatients who underwent surgery for parathyroid adenoma in our clinic between January 2007 and January2019 were included in the study. Clinical characteristics, biochemical data, treatment methods and results of the patients wereanalyzed retrospectively.Results: 156 patients with a mean age of 50.8 years participated in the study. Female sex was 76.2%. Preoperative calcium levelwas found as 11.2+1.02 mg/dl, Parathormone level was found as 114.7+109.5 pg / ml. The most common clinical presentationwas asymptomatic hypercalcemia (48.7%). While 89.7% of the patients had only parathoridectomy, 3.2% had total thyroidectomyand 7.1% had lobectomy due to associated thyroid pathology (10.3%). Intraoperative rapid parathormone was used in 54.4% ofthe patients. Frozen examination was performed in all patients. The most common localization was inferior left 39.7%. The mostcommon ectopic localization was intratymic at 2.6%. The mean duration of postoperative hospital stay was 3.81+2.69 days. Threepatients (1.9%) had persistent hyperparathyroidism and 6 patients (3.8%) had recurrent hyperparathyroidism. The mean follow-upwas 57.2+39.5 months.Conclusion: Proper preoperative evaluation, careful exploration, frozen examination and rapid parathormone test increase thesuccess of parathyroid adenoma surgery.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Uludag M, Aygun N. Primary Hyperparathyroidism: Current Situation in the Clinical and Biochemical Presentation. MedBull Sisli Etfal Hosp 2016;50:171– 80.
  • 2. Yeh MW, Ituarte PH, Zhou HC, et al. Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J Clin Endocrinol Metab 2013;98:1122-9.
  • 3. Pappachan JM, Elnaggar MN, Sodi R, et al. Primary hyperparathyroidism: findings from the retrospective evaluation of casesover a 6-year period from a regional UK centre. Endocrine 2018;62:174-81.
  • 4. Felger EA, Kandil E. Primary hyperparathyroidism. Otolaryngol Clin North Am 2010;43:417-32.
  • 5. Reid L, Muthukrishnan B, Patel D, et al Presentation, diagnostic assessment and surgical outcomes in primary hyperparathyroidism: a single centers experience. Endocrine Connections 2018;7:1105–15.
  • 6. Wilhelm SM, Wang TS, Ruan D, et al. The american association of endocrine surgeons guidelines for definitive management of primary hyperparathyroidism. JAMA Surg 2016;151:959–68.
  • 7. Sethi N, England RJA. Parathyroid surgery: from inception to the modern day. Br J Hosp Med (Lond) 2017;78:333-7.
  • 8. Tolley N, Garas G, Palazzo F, et al , Darzi A, Arora A Long-term prospective evaluation comparing robotic parathyroidectomy with minimally invasive open parathyroidectomy for primary hyperparathyroidism. Head Neck 2016;38:300–6.
  • 9. Bilezikian JP, Khan AA, Potts JT Jr, Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J ClinEndocrinol Metab 2009; 94: 335–39;
  • 10. Bilezikian JP, Brandi ML, Eastell R, et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metabolism 2014;99:3561-69.
  • 11. Khan AA, Hanley DA, Rizzoli R, et al .Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporos Int 2017;28:1–19.
  • 12. Irvin GL, Dembrow VD, Prudhomme DL. Operative monitoring of parathyroid gland hyperfunction. Am J Surg 1991;162:299-302.
  • 13. Khan A, Bilezikian J. Primary hyperparathyroidism: pathophysiology and impact on bone. CMAJ 2000;163:84–7.
  • 14. Bilezikian JP, Cusano NE, Khan AA, e t al. Primary hyperparathyroidism. Nat Rev Dis Prim 2016;2:16033.
  • 15. Percivale A, Gnerre P, Damonte G, et al. Management primary hyperparathyroidism: Epidemiology, clinical features, diagnostic tools and current. Italian J Med 2015;9:330-45.
  • 16. Clarke BL. Epidemiology of primary hyperparathyroidism. J Clin Densitom 2013;16:8-13.
  • 17. Wermers R, Clarke B. Epidemiology of primary hyperparathyroidism. In: Bilezikian J, Marcus R, Levine MA, et al, editors. Theparathyroids. 3rd ed. UK and USA: Elsevier 2015. p. 297-308.
  • 18. Press DM, Siperstein AE, Berber E, et al. The prevalence of undiagnosed and unrecognized primary hyperparathyroidism: a population-based analysis from the electronic medical record. Surgery 2013;154:1232-7.
  • 19. Callender GG, Udelsman R. Surgery for primary hyperparathyroidism. Cancer 2014;120:3602-16.
  • 20. Parnell KE, Oltmann SC The surgical management of primary hyperparathyroidism: an updated review. Int J Endo Oncol 2018:5,IJE07.
  • 21. Eastell R, Brandi ML, Costa AG, et al. Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of theFourth International Workshop. J Clin Endocrinol Metab 2014;99:3570-9.
  • 22. Fillee C, Keller T, Mourad M, et al. Impact of vitamin D-related serum PTH reference values on the diagnosis of mild primary hyperparathyroidism, using bivariate calcium/PTH reference regions. Clin Endocrinol. (Oxf.) 2012;76:785–9.
  • 23. 23-Usta A, Alhan E, Cinel A, Turkyilmaz S, Erem C A 20-year study on 190 patients with primary hyperparathyroidism in a developing country: Turkey experience. Int Surg 2015;100:648–55.
  • 24. Silva BC, Cusano NE, Bilezikian JP Primary hyperparathyroidism. Best Pract Res Clin Endocrinol Metab 2018;32:593–607.
  • 25. Lal G, Clark OH. Thyroid, parathyroid, and adrenal. In: Brunicardi FC, Anderson DK, Billiar TR, Dunn DL, Hunter JG, Matthews JB, et al. Schwartz’sPrinciples of Surgery. 10th ed. NewYork: McGrawHill 2015.1522- 96.
  • 26. Vignali E, Viccica G, Diacinti D, et al. Morphometric vertebral fractures in postmenopausal women with primary hyperparathyroidism. J Clin Endocrinol Metab 2009;94:2306-12.
  • 27. Wermers RA, Khosla S, Atkinson EJ, et al. Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993-2001: an update on the changing epidemiology of the disease. J Bone MinerRes 2006;21:171-7.
  • 28. Potts JT Jr. Management of asymptomatic hyperparathyroidism: a report on the NIH consensus developmentc conference. Trends Endocrinol Metab 1992;10:376-80.
  • 29. Johnson NA, Tublin ME, Ogilvie JB. Parathyroid imaging: technique and role in the preoperative evaluation of primary hyperparathyroidism. AJR 2007;188:1706–15.
  • 30. Palmer M, Adami HO, Bergstrom R, et al. Survival and renal function in untreated hypercalcemia. Populationbased cohort studywith 14 years of follow- up. Lancet 1987;1:59-62.
  • 31. Lumachi F, Zucchetta P, Marzola MC, et al. Advantages of combined technetium-99msestamibi scintigraphy and high-resolution ultrasonography in parathyroid localization: comparative study in 91 patients with primary hyperparathyroidism. Eur J Endocrinol 2000;143:755–60.
  • 32. Karateke F. Surgical Approach For Parathyroid Adenomas (Uzmanlık tezi).Adana, Çukurova Üniversitesi 2010.
  • 33. Morita SY, Somervell H, Umbricht CB, et al. Evaluation for concomitant thyroid nodules and primary hyperparathyroidism in patients undergoing parathyroidectomy or thyroidectomy. Surgery 2008;144:862–66.
  • 34. Wang CA: Hyperfunctioning Intra Thyroid Parathyroid Gland. A Potential Cause of Failure in Parathyroid Surgery. J R Soc Med 1981;74:49-54,
  • 35. Rossi RL, Cady B: Surgery of Parathyroid Glands, In: Surgery of theThyroid and Parathyroid Glands. Cady B, Rossi RL (eds), WB Saunders, Philadelphia, 1991. pp: 283-94.
  • 36. Shen W, Duren M, Morita E: Reoperation for Persistent or Recurrent Primary Hyperparathyroidism. ArchSurg 1996;131:861-7.
  • 37. Paek SH, Kim SJ, Choi JY, et al. Clinical usefulness of intraoperative parathyroid hormone monitoring for primary hyperparathyroidism. AnnSurgTreatRes 2018;94:69–73.
  • 38. Alhefdhi A, Pinchot SN, Davis R, et al. The necessity and reliability of intraoperative parathyroid hormone (PTH) testing in patients with mild hyperparathyroidism and PTH levels in the normal range. World J Surg 2011;35:2006–9.
  • 39. Temiz A, Turgut MS. Clinical, diagnosis, localization studies and treatment in primary hyperparathyroidism. J Harran University Med Facult 2018;15:40-44.
  • 40. Elaraj DM, Remaley AT, Simonds WF, et al Utility of rapid intraoperative parathyroid hormone assay to predict severe postoperative hypocalcemia after reoperation for hyperparathyroidism. Surgery 2002;132:1028–33.
APA Topal U, Dalcı K, Unal A, SARITAŞ A, GÜNAY I, UĞUZ A, SAKMAN G (2019). Clinical and surgical approach to parathyroid adenomas: A single-center experience. , 2259 - 2265. 10.5455/annalsmedres.2019.08.471
Chicago Topal Uğur,Dalcı Kubilay,Unal Ayse Gizem,SARITAŞ Ahmet Gökhan,GÜNAY Isa Burak,UĞUZ Aysun Hatice,SAKMAN GURHAN Clinical and surgical approach to parathyroid adenomas: A single-center experience. (2019): 2259 - 2265. 10.5455/annalsmedres.2019.08.471
MLA Topal Uğur,Dalcı Kubilay,Unal Ayse Gizem,SARITAŞ Ahmet Gökhan,GÜNAY Isa Burak,UĞUZ Aysun Hatice,SAKMAN GURHAN Clinical and surgical approach to parathyroid adenomas: A single-center experience. , 2019, ss.2259 - 2265. 10.5455/annalsmedres.2019.08.471
AMA Topal U,Dalcı K,Unal A,SARITAŞ A,GÜNAY I,UĞUZ A,SAKMAN G Clinical and surgical approach to parathyroid adenomas: A single-center experience. . 2019; 2259 - 2265. 10.5455/annalsmedres.2019.08.471
Vancouver Topal U,Dalcı K,Unal A,SARITAŞ A,GÜNAY I,UĞUZ A,SAKMAN G Clinical and surgical approach to parathyroid adenomas: A single-center experience. . 2019; 2259 - 2265. 10.5455/annalsmedres.2019.08.471
IEEE Topal U,Dalcı K,Unal A,SARITAŞ A,GÜNAY I,UĞUZ A,SAKMAN G "Clinical and surgical approach to parathyroid adenomas: A single-center experience." , ss.2259 - 2265, 2019. 10.5455/annalsmedres.2019.08.471
ISNAD Topal, Uğur vd. "Clinical and surgical approach to parathyroid adenomas: A single-center experience". (2019), 2259-2265. https://doi.org/10.5455/annalsmedres.2019.08.471
APA Topal U, Dalcı K, Unal A, SARITAŞ A, GÜNAY I, UĞUZ A, SAKMAN G (2019). Clinical and surgical approach to parathyroid adenomas: A single-center experience. Annals of Medical Research, 26(10), 2259 - 2265. 10.5455/annalsmedres.2019.08.471
Chicago Topal Uğur,Dalcı Kubilay,Unal Ayse Gizem,SARITAŞ Ahmet Gökhan,GÜNAY Isa Burak,UĞUZ Aysun Hatice,SAKMAN GURHAN Clinical and surgical approach to parathyroid adenomas: A single-center experience. Annals of Medical Research 26, no.10 (2019): 2259 - 2265. 10.5455/annalsmedres.2019.08.471
MLA Topal Uğur,Dalcı Kubilay,Unal Ayse Gizem,SARITAŞ Ahmet Gökhan,GÜNAY Isa Burak,UĞUZ Aysun Hatice,SAKMAN GURHAN Clinical and surgical approach to parathyroid adenomas: A single-center experience. Annals of Medical Research, vol.26, no.10, 2019, ss.2259 - 2265. 10.5455/annalsmedres.2019.08.471
AMA Topal U,Dalcı K,Unal A,SARITAŞ A,GÜNAY I,UĞUZ A,SAKMAN G Clinical and surgical approach to parathyroid adenomas: A single-center experience. Annals of Medical Research. 2019; 26(10): 2259 - 2265. 10.5455/annalsmedres.2019.08.471
Vancouver Topal U,Dalcı K,Unal A,SARITAŞ A,GÜNAY I,UĞUZ A,SAKMAN G Clinical and surgical approach to parathyroid adenomas: A single-center experience. Annals of Medical Research. 2019; 26(10): 2259 - 2265. 10.5455/annalsmedres.2019.08.471
IEEE Topal U,Dalcı K,Unal A,SARITAŞ A,GÜNAY I,UĞUZ A,SAKMAN G "Clinical and surgical approach to parathyroid adenomas: A single-center experience." Annals of Medical Research, 26, ss.2259 - 2265, 2019. 10.5455/annalsmedres.2019.08.471
ISNAD Topal, Uğur vd. "Clinical and surgical approach to parathyroid adenomas: A single-center experience". Annals of Medical Research 26/10 (2019), 2259-2265. https://doi.org/10.5455/annalsmedres.2019.08.471